🔎 Trials Near Me

Akèy › Maladi poumon › Massachusetts › Boston

Etid klinik pou Maladi poumon nan Boston, MA

14 etid pou Maladi poumon ap chèche patisipan nan sit nan ak bò kote Boston (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

Ap rekriteFaz 3
  • Dana-Farber Cancer Institute, Boston
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT06765109

A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease

Ap rekriteFaz 3
  • Brigham and Women's Hospital, Boston
Laj 12 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06679140

A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised

Ap rekriteFaz 3
  • Brigham and Women's Hospital, Boston
  • Clinical Trials Center, Boston
  • Clinical Trials Hub, Boston
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07013474

A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

Ap rekriteFaz 2
  • Brigham and Women's Hospital, Boston
Laj 40 a 75 · Tout sèks · Mizajou Sep 25, 2026 · NCT07759245

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Ap rekriteFaz 1/2
  • Dana Farber Cancer Institute, Boston
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT06128551

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Ap rekriteFaz 3
  • Boston Medical Center, Boston
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT06119581

A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD

Ap rekriteFaz 2
  • Clinical Research Site, Boston
Laj 18 a 85 · Tout sèks · Mizajou Sep 2, 2026 · NCT07333183

A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.

Ap rekriteFaz 2
  • Beth Israel Deaconess Medical Center, Boston
Laj 18 ak plis · Tout sèks · Mizajou Sep 1, 2026 · NCT05967689

BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)

Ap rekriteFaz 2
  • Dana-Farber Cancer Institute, Boston
  • Boston Children's Hospital, Boston
  • Brigham and Women's Hospital, Boston
Laj 18 ak plis · Tout sèks · Mizajou Jun 10, 2026 · NCT05922761

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

Ap rekriteFaz 1/2
  • Massachusetts General Hospital,, Boston
Laj 12 ak plis · Tout sèks · Mizajou May 27, 2026 · NCT03093116

Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy

Ap rekrite
  • VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA, Boston
Laj 18 ak plis · Tout sèks · Mizajou Feb 19, 2026 · NCT02984761

A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)

Ap rekriteFaz 2
  • Dana-Farber Cancer Institute, Boston
Laj 18 ak plis · Tout sèks · Mizajou Dec 15, 2025 · NCT06619561

Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System

Ap rekrite
  • Brigham and Women's Hospital, Boston
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2025 · NCT04555161

Etid Maladi poumon nan lòt vil

Lòt etid nan Boston

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.